MAPT and Alzheimer disease: The seemingly-less “handing-over” of Tau between the MT surface and chaperoning 14-3-3 dimers could underlie pathological Tau aggregation occurring when Tau phosphorylation increases and 14-3-3 levels and other complementary homeostatic mechanisms start to deteriorate, for example in the AD brain.